Veriheal

NOVEMBER 17, 2020

Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. But this has failed in the past and could prevent measures from moving forward this time unless new research could be presented to sway the state medical board’s decision.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

MMJ Recs

FEBRUARY 3, 2024

In recent years, the landscape of medical marijuana laws has evolved, presenting new opportunities and challenges for patients, healthcare providers, and industry stakeholders. These laws outline the parameters for the cultivation, distribution, and use of medical cannabis within the city.

Legislation 52

Legislation Law Marijuana Dispensary 52

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Current Texas Medical Marijuana Regulations CBD laws in Texas are governed by the Compassionate Use Program.

Law 52

Law Dispensary Clinical Trials Programs 52

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

AUGUST 15, 2021

Aims to support acceleration of clinical development of low-dose psilocybin in SUNHA and 5MeO-DMT in other neuro-psychiatric indications. The progress Beckley Psytech has made in attracting exceptional talent to the team and advancing our ambitious clinical development programmes over the past two years has been tremendously exciting.

Medicine 98

Medicine Research and Development Conditions Treatment 98

United Patients Group

OCTOBER 25, 2023

To address these concerns and provide clear, evidence-based answers to the most frequently asked questions about medical marijuana, we have compiled a comprehensive FAQ to help both patients and the general public make educated decisions about their healthcare options. Virgin Islands permitting its use for certain medical conditions.

Marijuana 91

Marijuana Patients Research and Development Edibles 91

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis research problem. What makes a good research study, anyway?

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JULY 29, 2021

Ben Kaplan, CEO of Ehave, said, “We strongly believe there is a genetic predisposition to this condition and will be conducting a large-scale genetic analysis to isolate an individuals’ risk profile. Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question.

Research and Development 105

Research and Development Conditions Data Patients 105

The Cannigma

JUNE 4, 2023

Peru has undergone significant changes in its cannabis laws in recent years, reflecting a more progressive approach compared to many other countries. Patients with qualifying medical conditions can access cannabis-based products with a prescription from authorized healthcare professionals.

Law 52

Law Seed-To-Sale Research and Development Cultivation 52

Cannabis Law Report

JULY 13, 2021

Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].

Medicine 105

Medicine Research and Development Agriculture Strains 105

Cannabis Law Report

JULY 2, 2021

According to the legislative piece, in 2017, the “Law to Manage the Study, Development and Research of Cannabis for Innovation, Applicable Standards and Limits” was signed. However, the measure did not become law. Despite the authorization of the use of medical cannabis, there is legal hypocrisy.

Patients 104

Patients Research and Development Legislation Conditions 104

Cannabis Law Report

MARCH 24, 2022

Rather, it’s a modest bipartisan piece of legislation that’s simply meant to promote research into marijuana. JUST IN: The Senate passed my bill with Senators Grassley and Schatz to cut red tape around the research process of marijuana and marijuana-derived medications. — Senator Dianne Feinstein (@SenFeinstein) March 24, 2022.

Research and Development 52

Research and Development Legislation Patients Safety 52

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

SpeedWeed

JUNE 2, 2021

New Hampshire Governor Chris Sununu (R) just signed a bill to expand the list of qualifying conditions for the state’s medical marijuana program. Doctors will also be able to recommend medical pot to minors with ASD, but only if they can confirm that the patient has not responded to conventional medications or treatments.

Conditions 52

Conditions Programs Research and Development Marijuana 52

MMJ Recs

FEBRUARY 10, 2024

Scientific research, patient testimonials, and a broader understanding of the plant’s medicinal properties have fundamentally altered public views. This change is driven by a combination of scientific research, increased education, and a desire for alternative healthcare options.

Research and Development 105

Research and Development Marijuana History Legislation 105

MMJ Recs

MAY 9, 2024

Many veterans struggle with various physical and psychological conditions resulting from their service. These professionals can provide valuable insights into whether medical cannabis is a suitable option based on the veteran’s medical history, current conditions, and treatment goals.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

JUNE 21, 2021

At the moment, Japan does not have any medical cannabis program for their patients. But, as more and more researchers are suggesting the use of marijuana for medical conditions, the restriction might be less strict in the future. Therefore, you have to wait longer for the cannabis law to become lenient in this country.

Law 103

Law Seed-To-Sale Research and Development Consumption 103

United Patients Group

JULY 7, 2023

In recent years, there has been a growing interest in the use of medical cannabis to manage a variety of health conditions. Medical cannabis, also known as medical marijuana, refers to the use of the cannabis plant or its extracts to treat symptoms of disease or other medical conditions.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

The Cannigma

OCTOBER 14, 2022

However, the laws don’t differentiate between soft drugs and hard drugs. Established in 2016 by a citizen’s initiative, patients can purchase cannabis-based medicines like Sativex to treat a number of approved conditions including multiple sclerosis, spine injuries, and neuropathic pain. San Marino medical marijuana program.

Law 56

Law Clinical Trials Research and Development Recreational 56

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. This process involves various stages, including cultivation, processing, packaging, distribution, and retailing.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

JULY 24, 2021

Argel Aguilar-Valles at Carleton University (“Carleton”) Department of Neuroscience by the Accelerate program at Mitacs for research into the anxiolytic potential of TD-010 in preclinical models of chronic anxiety and depression. About BetterLife Pharma. BetterLife Pharma Inc. For further information, please visit www.abetterlifepharma.com.

Research and Development 98

Research and Development Treatment Therapy Media 98

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. So, why did this educational gap develop? Unfortunately, this did not occur.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. Forward-Looking Statements.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

JULY 27, 2021

.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., as its Research Director, a new role in the organization’s leadership. This study represents a refreshing collaboration of scientists, clinicians, patients and advocates.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Cannabis Law Report

JUNE 3, 2021

(OTCQB:KOAN), a Wellness Lifestyle cannabis holding company (“Resonate” or “the Company”), announced today it has retained the services of Colleen Quinn, an internationally celebrated clinical aromatherapist, cosmetic chemist, researcher and educator.

Research and Development 87

Research and Development Education Therapy Programs 87

Cannabis Law Report

JUNE 19, 2022

Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model. This latest partnership further strengthens Beckley Psytech’s digital strategy to develop personalised, end-to-end treatment programmes for patients in areas of significant unmet medical need.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

Cannabis Law Report

AUGUST 3, 2022

As our firm’s prior information memos on cannabis have shown 1 , the legalization of marijuana for recreational or medical use in states still poses legal issues in higher education due to marijuana’s illegality under federal law. This tension in laws is also present in the issue of marijuana use by patients in hospital settings.

Research and Development 98

Research and Development Policy Patients Compliance 98

Veriheal

NOVEMBER 9, 2023

Traditional treatments for these conditions often involve medication, physical therapy, or more invasive interventions like surgery. This exciting development could have profound implications for how we approach managing this type of pain. However, these approaches are not always practical for everyone. How Does Cannabis Spray Work?

Treatment 109

Treatment Therapy Research and Development THC 109

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. Published Via JD Supra. Psychedelic therapy is not a fringe phenomenon.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

JUNE 8, 2021

OTCQB: SILO) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, is pleased to announce that it has entered into a Scientific Research Agreement (SRA) with the University of California San Francisco (UCSF). Englewood Cliffs, NJ, June 08, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc.

Patients 92

Patients Research and Development Clinical Trials Chronic Pain 92

Cannabis Law Report

DECEMBER 26, 2021

The patent relates to improved technology for detection and maintenance of the optimal therapeutic psychedelic state, which Entheon intends to study through the monitoring of electroencephalogram (EEG) biomarkers in order to optimize the treatment of neuropsychiatric conditions. . – December 16, 2021) – Entheon Biomedical Corp.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

The Cannigma

MARCH 14, 2023

Those who were already under close watch by law enforcement because of structural racism, as well as those who were responsible for the well being of others had to be very careful about how they were perceived by those in control of the laws. And the truth was that many of the early medical cannabis patients were severely ill.

Policy 96

Policy Research and Development Conditions Consumption 96

Cannabis Law Report

JULY 8, 2021

The study is the first of its kind and will be conducted within Swinburne’s Drugs and Driving Research unit, which is led by Professor Downey. ‘We We are grateful for this grant, and especially for the opportunity to further our research in this space,’ says Professor Downey. ‘It Medicinal Cannabis Research Collaboration (MCRC).

Medicine 98

Medicine Research and Development Safety THC 98

Healer

JUNE 20, 2023

  The Healer Cannabis and Dementia webinar includes the latest research and case studies of patients successfully using cannabis and hemp to help with dementia challenges such as agitation, wandering, aggressive behaviors, poor nutrition, pain, sleep and even cognitive abilities.

Research and Development 98

Research and Development Sleep Topical Hemp 98